Co-delivery of paclitaxel and anti-VEGF siRNA by tripeptide lipid nanoparticle to enhance the anti-tumor activity for lung cancer therapy

The combination of chemotherapeutic drug paclitaxel (PTX) and VEGF siRNA could inhibit cancer development with synergistic efficacy. However, efficient and safe delivery systems with high encapsulation efficiency of PTX and a long-time release of drugs are urgently needed. In this study, novel nanop...

全面介紹

Na minha lista:
書目詳細資料
發表在:Drug Deliv
Main Authors: Zhang, Chuanmin, Zhao, Yinan, Zhang, Enxia, Jiang, Meilin, Zhi, Defu, Chen, Huiying, Cui, Shaohui, Zhen, Yuhong, Cui, Jingnan, Zhang, Shubiao
格式: Artigo
語言:Inglês
出版: Taylor & Francis 2020
主題:
Research Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7594708/
https://ncbi.nlm.nih.gov/pubmed/33096948
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10717544.2020.1827085
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍